Neumora Therapeutics, Inc. (NMRA) cash on hand

Cash · fiscal 2025
$182.53M

Neumora Therapeutics, Inc. (NMRA) held cash of $182.53M at the end of fiscal 2025 (December 31, 2025). That is 40.7% lower than the $307.58M of fiscal 2024. Figures as of 18 Nov 2026, 12:35 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
$182.53M
Change on fiscal 2024
−40.7%
Highest on record
$453.98Mfiscal 2023
Lowest on record
$182.53Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Neumora Therapeutics, Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $453.98M in fiscal 2023 and the lowest $182.53M in fiscal 2025.

History · 4 fiscal years

Cash by fiscal year

Neumora Therapeutics, Inc. cash on hand, year by year

Neumora Therapeutics, Inc. (NMRA) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$182.53M 40.7% down
2024$307.58M 32.2% down
2023$453.98M 22.1% up
2022$371.88M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on NMRA

Neumora Therapeutics, Inc., figure by figure

Neumora Therapeutics, Inc. (NMRA) overview: price, valuation and scorecard

Neumora Therapeutics, Inc. cash on hand: questions and answers

How much cash does Neumora Therapeutics, Inc. have?

Neumora Therapeutics, Inc. (NMRA) held cash of $182.53M at the end of fiscal 2025 (December 31, 2025). That is 40.7% lower than the $307.58M of fiscal 2024.

What are the highest and lowest cash figures on record for Neumora Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $453.98M in fiscal 2023 and the lowest $182.53M in fiscal 2025.

How is Neumora Therapeutics, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Neumora Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Neumora Therapeutics, Inc. (NMRA) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/NMRA/cash

Underlying data: Yahoo Finance.